Pilot Study of Thalidomide to Treat Sjogren's Syndrome

NCT00001599 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

NIH

Sponsor class

Conditions

Sjogren's Syndrome
Xerostomia

Interventions

DRUG: Thalidomide

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)